Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month for a limited time. Business Insider: Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare® Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare® Investing.com India: Weight Watchers stock jumps on new Eli Lilly GLP-1 offering Investing.com -- Weight Watchers (NASDAQ:WW) shares rose 17% Thursday after the company announced it will offer Eli Lilly and Company’s newly FDA-approved oral GLP-1 medication Foundayo (orforglipron) ... Markets Insider: Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect WeightWatchers Med+ is now offering an oral GLP-1 medication for weight loss.

Understanding the Context

The new daily pill is the first FDA-approved oral GLP-1 for weight management. Clinical trials showed weight loss results ... FinanzNachrichten.de: WW International Inc.: Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo Available Through LillyDirect WW International Inc.: Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo Available Through LillyDirect